Ungated Post | 06 Mar 2020
Making cells better: Complex challenges drive innovation in cell and gene therapy manufacturing
The processes required for C> manufacture are wholly new and extremely complex. As production and delivery of these new therapies to patients are still nascent, biopharmaceutical companies will need to harness new technological advances and innovate continuously in the manufacturing process.
Large capital investments in the industry are likely to bring breakthroughs in the coming years that will standardise processes, simplify delivery logistics, boost efficiency, and increase competition.
Our Thought Leadership team produces original, evidence-based research made accessible to decision-makers and opinion leaders. Principals for this project included:
Oxford Economics’ team is expert at applying advanced economic tools that provide valuable insights into today’s most pressing business, financial, and policy issues.
To find out more about our capabilities, contact:
EMEA
Paul Donnelly
020 3910 8000
Email
Americas
Jeffrey Klonoski
+1 646 503 3048
Email
Asia
Christie Tang
+852 3974 8841
Email
Related Services
Post
From opportunity to impact – Assessing the economic, societal, and cultural benefits of YouTube in Sweden
This study assesses YouTube's contribution to GDP and employment in Sweden, and its broader impact on society and culture.
Find Out More
Post
Från möjlighet till påverkan – Utvärdering av de ekonomiska, sociala och kulturella fördelarna med YouTube i Sverige
Denna studie utvärderar YouTubes påverkan på Sveriges BNP och sysselsättningsgrad samt samhället och kulturen.
Find Out More
Post
The economic importance of motorcycles to Europe – technical report
Motorcycle-related activity supports €21.4 billion of output (GDP) across Europe a year, sustains 389,000 jobs, and generates €16.6 billion of tax revenues, according to research by Oxford Economics.
Find Out More